Mm. Loureiro et al., AN UNUSUAL CASE OF PAPILLARY CARCINOMA OF THE THYROID WITH CUTANEOUS AND BREAST METASTASES ONLY, European journal of endocrinology, 137(3), 1997, pp. 267-269
Cutaneous metastases of thyroid carcinoma are infrequent and, when pre
sent, are usually located in the vicinity of a widespread primary tumo
r. Breast metastases from these tumors are even less common. We report
the case of a 64-year-old female with a toxic multinodular goiter in
whom a fine-needle biopsy, performed in 1985 at the age of 52, was sug
gestive of papillary carcinoma of the thyroid. Total thyroidectomy for
a papillary carcinoma, follicular variant, was performed in 1988. Fou
r months after surgery, a cutaneous metastasis was discovered in the r
ight thigh. Surgical excision of this lesion followed by treatment wit
h radioactive iodine decreased serum Tg levels from 7495 to 3.3 mu g/l
. Under suppressive therapy with L-thyroxine, serum Tg remained undete
ctable for the next 4 years. Then, serum Tg levels rose to 3.9-5.6 mu
g/l and a second cutaneous metastasis was removed from the abdominal w
all. The patient was again treated with radioactive iodine and the pos
t-treatment whole-body scan did not show any area of increased uptake
of the radionuclide. However, serum Tg levels under suppression with L
-thyroxine remained elevated at 4-20 mu g/l for the next 2 years. In A
ugust 1995, a 1.5 cm nodule was found in the right breast. Cytological
examination was suggestive of a breast metastasis from thyroid. carci
noma and the lesion was removed by enucleation. This proved to be a me
tastasis from a papillary carcinoma of the thyroid. Elevated (19-44 mu
g/l) serum Tg levels persisted postoperatively. A third cutaneous met
astasis was revealed by I-131 scintigraphy in the right buttock and su
rgically removed in December 1996. Serum Tg levels have remained undet
ectable since then. To the best of our knowledge, this is a unique cas
e of a papillary carcinoma of the thyroid with a propensity to metasta
size only to the skin and breast during a follow-up of 11 years.